BioStem Technologies, Inc.
BSEM
$11.26
-$0.6979-5.84%
OTC PK
| 09/30/2024 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 30.25% | 30.25% | 16.56% | 58.93% | 218.84% |
| Total Depreciation and Amortization | 95.09% | 95.09% | -5.21% | -1.93% | -4.95% |
| Total Amortization of Deferred Charges | 491.12% | 491.12% | -19.06% | -19.06% | -80.76% |
| Total Other Non-Cash Items | -150.03% | -150.03% | 44.24% | 44.24% | 78.12% |
| Change in Net Operating Assets | 231.08% | 231.08% | 49.19% | 39.29% | -729.35% |
| Cash from Operations | 50.09% | 50.09% | 1,029.08% | 1,037.03% | 139.27% |
| Capital Expenditure | 23.25% | 23.25% | -1,190.32% | -1,190.32% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -758.00% | -758.00% | -1,190.32% | -1,190.32% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 32.47% | 32.47% | 45.76% | 45.23% | 14.76% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -87.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 79.53% | 79.53% | -49.86% | -53.99% | -108.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 35.63% | 35.63% | 1,368.28% | 1,368.28% | 211.81% |